Have your own idea? Try our Stock Screener
U.S. Biotech Industry Analysis
UpdatedJun 03, 2025
DataAggregated Company Financials
Companies567
- 7D1.5%
- 3M-7.3%
- 1Y-11.5%
- YTD-4.3%
Over the last 7 days, the Biotech industry has remained flat, although notably Amgen gained 6.2%. Unfortunately though, the industry is down 13% over the past 12 months. Earnings are forecast to grow by 24% annually.
Industry Valuation and Performance
Has the U.S. Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 03 Jun 2025 | US$908.2b | US$155.9b | -US$24,019,913,159.22 | 15.5x | -37.8x | 5.8x |
| Thu, 01 May 2025 | US$799.1b | US$119.3b | -US$30,873,699,546.22 | 20.7x | -25.9x | 6.7x |
| Sat, 29 Mar 2025 | US$823.8b | US$118.6b | -US$37,131,150,475.30 | 24.4x | -22.2x | 6.9x |
| Mon, 24 Feb 2025 | US$863.6b | US$117.3b | -US$37,606,528,073.37 | 17x | -23x | 7.4x |
| Wed, 22 Jan 2025 | US$947.4b | US$149.5b | -US$26,308,825,526.65 | 17.5x | -36x | 6.3x |
| Fri, 20 Dec 2024 | US$957.4b | US$149.9b | -US$26,462,994,425.39 | 15.5x | -36.2x | 6.4x |
| Sun, 17 Nov 2024 | US$991.1b | US$150.0b | -US$26,801,381,083.88 | 17.2x | -37x | 6.6x |
| Tue, 15 Oct 2024 | US$902.0b | US$113.1b | -US$36,040,263,614.54 | 20.6x | -25x | 8x |
| Thu, 12 Sep 2024 | US$904.6b | US$113.1b | -US$35,666,524,615.23 | 22.3x | -25.4x | 8x |
| Sat, 10 Aug 2024 | US$856.5b | US$112.6b | -US$37,136,901,661.41 | 21.6x | -23.1x | 7.6x |
| Mon, 08 Jul 2024 | US$1.1t | US$164.5b | -US$28,073,537,735.64 | 27.9x | -40.3x | 6.9x |
| Wed, 05 Jun 2024 | US$1.1t | US$164.6b | -US$26,652,225,135.77 | 27.8x | -42.5x | 6.9x |
| Fri, 03 May 2024 | US$1.1t | US$163.6b | -US$26,775,356,164.78 | 24.8x | -41x | 6.7x |
| Sun, 31 Mar 2024 | US$1.2t | US$164.4b | -US$23,602,941,195.66 | 21.6x | -50x | 7.2x |
| Tue, 27 Feb 2024 | US$1.2t | US$166.9b | -US$21,602,631,007.37 | 13.5x | -55.1x | 7.1x |
| Thu, 25 Jan 2024 | US$1.4t | US$204.7b | -US$22,524,950,232.00 | 18.2x | -63.9x | 7x |
| Sat, 23 Dec 2023 | US$1.4t | US$204.9b | -US$22,145,415,775.00 | 19.4x | -61.9x | 6.7x |
| Mon, 20 Nov 2023 | US$1.2t | US$204.7b | -US$22,041,460,760.00 | 18.1x | -55.3x | 6x |
| Wed, 18 Oct 2023 | US$1.3t | US$207.4b | -US$13,066,450,907.00 | 17.3x | -97.1x | 6.1x |
| Fri, 15 Sep 2023 | US$1.3t | US$207.5b | -US$12,636,400,679.00 | 17.6x | -101.2x | 6.2x |
| Sun, 13 Aug 2023 | US$1.3t | US$207.7b | -US$12,540,100,481.00 | 17.1x | -102.7x | 6.2x |
| Tue, 11 Jul 2023 | US$1.1t | US$186.4b | -US$16,008,439,670.00 | 13.2x | -70x | 6x |
| Thu, 08 Jun 2023 | US$1.1t | US$186.0b | -US$16,014,822,818.00 | 11.7x | -71.2x | 6.1x |
| Sat, 06 May 2023 | US$1.2t | US$192.6b | -US$12,088,374,569.00 | 15.6x | -97.1x | 6.1x |
| Mon, 03 Apr 2023 | US$1.2t | US$217.0b | -US$6,024,358,980.00 | 14.3x | -192.4x | 5.3x |
| Wed, 01 Mar 2023 | US$1.1t | US$199.6b | -US$4,168,872,201.00 | 15.4x | -271.3x | 5.7x |
| Fri, 27 Jan 2023 | US$1.2t | US$203.8b | US$1.8b | 14.8x | 660.1x | 5.7x |
| Sun, 25 Dec 2022 | US$1.2t | US$203.3b | US$1.6b | 14.5x | 703.1x | 5.7x |
| Tue, 22 Nov 2022 | US$1.1t | US$202.1b | US$1.2b | 14.7x | 915.5x | 5.5x |
| Thu, 20 Oct 2022 | US$1.0t | US$206.1b | US$5.4b | 15.6x | 191.2x | 5x |
| Sat, 17 Sep 2022 | US$1.1t | US$206.6b | US$5.8b | 14.7x | 184.5x | 5.2x |
| Mon, 15 Aug 2022 | US$1.1t | US$206.8b | US$7.3b | 15.9x | 154.7x | 5.4x |
| Wed, 13 Jul 2022 | US$1.1t | US$211.3b | US$10.7b | 17.2x | 101.6x | 5.1x |
| Fri, 10 Jun 2022 | US$993.8b | US$212.7b | US$11.2b | 15.5x | 88.5x | 4.7x |
Price to Earnings Ratio
88.5x
Current Industry PE
- Investors are relatively neutral on the American Biotechs industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 6.3x.
Past Earnings Growth
- Total earnings for the Biotechs industry have declined over the last three years, with the industry now making a loss overall.
- Revenues have also declined 9.8% per year, which is driving profits down.
Industry Trends
Which industries have driven the changes within the U.S. Healthcare industry?
| US Market | 2.04% | |
| Healthcare | 2.02% | |
| Biotech | 1.50% | |
| Biotech | 1.50% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| AMGN Amgen | US$288.47 | 6.2% +US$9.0b | -6.2% | PE26.1x | |
| ABBV AbbVie | US$186.99 | 2.0% +US$6.6b | 16.7% | PE79.5x | |
| BNTX BioNTech | US$113.10 | 14.6% +US$3.5b | 9.9% | PS8.7x | |
| VRTX Vertex Pharmaceuticals | US$445.43 | 2.2% +US$2.4b | -5.3% | PS10.3x | |
| ALNY Alnylam Pharmaceuticals | US$306.09 | 5.6% +US$2.1b | 103.4% | PS17x |
